Sharda Cropchem reported robust financial results for the quarter, with consolidated revenue up 25% to Rs. 984.8 Cr.

PAT surged 424% to Rs. 142.8 Cr, driven by 13% volume growth and improved pricing.

EBITDA jumped 67% to Rs. 142.2 Cr, expanding margins to 14.4%. The company remains debt-free with Rs. 791 Cr in liquid investments.

Management aims for 15% topline growth and 15-18% EBITDA margins for FY26, supported by planned capex of Rs. 400-450 Cr and ongoing product registrations.